Literature DB >> 5728318

Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid.

H C Guldberg, C M Yates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5728318      PMCID： PMC1570240          DOI： 10.1111/j.1476-5381.1968.tb00494.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  19 in total

1.  On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

Authors:  N E ANDEN; B E ROOS; B WERDINIUS
Journal:  Life Sci (1962)       Date:  1963-07

2.  Topographical differences in the cerebral metabolism of DL-2-14C-3,4-dihydroxphenylalanine.

Authors:  A PLETSCHER; K F GEY
Journal:  Experientia       Date:  1962-11-15

3.  Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine.

Authors:  A CARLSSON; N A HILLARP
Journal:  Acta Physiol Scand       Date:  1962-05

4.  On the role of monoamine oxidase for the inactivation of dopamine in brain.

Authors:  E ROSENGREN
Journal:  Acta Physiol Scand       Date:  1960-08-25

5.  On the presence of 3-hydroxytyramine in brain.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON; B WALDECK
Journal:  Science       Date:  1958-02-28       Impact factor: 47.728

6.  Effect of reserpine on the level of 5-hydroxyindoleacetic acid in brain.

Authors:  B E ROOS; B WERDINIUS
Journal:  Life Sci (1962)       Date:  1962-03

7.  On the mechanism of chlorpromazine-induced changes of cerebral homovanillic acid levels.

Authors:  M Da Prada; A Pletscher
Journal:  J Pharm Pharmacol       Date:  1966-09       Impact factor: 3.765

8.  Homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in serial samples of cerebrospinal fluid from the lateral ventricle of the dog.

Authors:  G W Ashcroft; T B Crawford; R C Dow; H C Guldberg
Journal:  Br J Pharmacol Chemother       Date:  1968-07

9.  The effect of drugs on the homovanillic acid content of the corpus striatum of some rodents.

Authors:  A V Juorio; D F Sharman; T Trajkov
Journal:  Br J Pharmacol Chemother       Date:  1966-02

10.  Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.

Authors:  D F Sharman
Journal:  Br J Pharmacol Chemother       Date:  1966-11
View more
  15 in total

1.  Amine metabolites in the cerbrospinal fluid in Huntington's chorea.

Authors:  G Curzon; J Gumpert; D Sharpe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-08       Impact factor: 10.154

2.  5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.

Authors:  B Johansson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

3.  Homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in serial samples of cerebrospinal fluid from the lateral ventricle of the dog.

Authors:  G W Ashcroft; T B Crawford; R C Dow; H C Guldberg
Journal:  Br J Pharmacol Chemother       Date:  1968-07

4.  Amine metabolism in brain.

Authors:  G W Ashcroft
Journal:  Proc R Soc Med       Date:  1969-11

Review 5.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.

Authors:  D L Davidson; C M Yates; C Mawdsley; I A Pullar; H Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-12       Impact factor: 10.154

7.  A comparison of D and L-tryptophan on the cerebral metabolism of 5-hydroxytryptamine and dopamine in the dog.

Authors:  J Budny; R C Dow; D Eccleston; A G Hill; I M Ritchie
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

8.  Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.

Authors:  D G Grahame-Smith
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

9.  Effects of chlorpromazine on the metabolism of catecholamines in dog brain.

Authors:  H C Guldberg; C M Yates
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

10.  Phenolic acid concentrations in the lumbar cerebrospinal fluid of Parkinsonian patients treated with L-dopa.

Authors:  I A Pullar; J M Weddell; R Ahmed; F J Gillingham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.